Marchés français ouverture 39 min

Atrion Corporation (ATRI)

NasdaqGS - NasdaqGS Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
427,80+17,62 (+4,30 %)
À la clôture : 04:00PM EDT
427,80 0,00 (0,00 %)
Échanges après Bourse : 04:02PM EDT

Atrion Corporation

One Allentown Parkway
Allen, TX 75002-4211
United States
972 390 9800
https://www.atrioncorp.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein712

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Emile A. BattatExecutive Chairman632,56kS.O.1938
Mr. David A. BattatPresident & CEO924,46kS.O.1970
Ms. Cindy FergusonVP, CFO, Secretary & Treasurer363,25kS.O.1976
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Atrion Corporation en date du 1 mai 2024 est 6. Les scores principaux sont Audit : 9; Société : 7; Droits des actionnaires : 4; Compensation : 5.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.